There currently exist many cardiac assist devices for the clinical treatment of congestive heart failure, which affects nearly 5 million Americans and costs the United States health care system nearly $32 billion annually . The majority of these clinical devices help to improve cardiac perfusion by utilizing a blood pump — either pulsatile or continuous flow — cannulated to the circulatory system to create a parallel bypass for blood flow. These devices are typically very effective in the short term (days to months) but are typically limited by problems associated with chronic use . Some of the most prevalent complications stem from the need for long-term system anticoagulation, invasive implant surgeries, catastrophic wear and tear of mechanical parts or drivelines, and infections at the percutaneous driveline site. Therefore, there is a great medical need to develop new or improve existing technologies to minimize and/or eliminate these adverse events.
Development of Epicardial Circulatory Assist Devices: Material Considerations
- Views Icon Views
- PDF LinkPDF
- Share Icon Share
- Search Site
Soohoo, E, Aranda-Michel, E, Kaissar, M, & Trumble, DR. "Development of Epicardial Circulatory Assist Devices: Material Considerations." Proceedings of the 2018 Design of Medical Devices Conference. 2018 Design of Medical Devices Conference. Minneapolis, Minnesota, USA. April 9–12, 2018. V001T01A010. ASME. https://doi.org/10.1115/DMD2018-6891
Download citation file: